- Ticker
- ABOS
- Price
- 4.08
- Stock movement up
- +0.20 (5.15%)
- Company name
- Acumen Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Marknadsvärde
- 166.98M
- Ent-värde
- 16.05M
- Pris/omsättning
- -
- Pris/bok
- 0.85
- Direktavkastning
- -
- Utdelningens tillväxt
- -
- Tillväxt år
- -
- FCF-utbetalning
- -
- Efterföljande P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-tillväxt
- -
- 1 års avkastning
- -32.00%
- 3 års avkastning
- -
- 5 års avkastning
- -
- 10 års avkastning
- -
Senast uppdaterad: 2023-03-22
The following slide deck was published by Acumen Pharmaceuticals, Inc.
27 mars 2023
iO Charts is a Seeking Alpha partner
Acumen Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ABOS) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ETCompany ParticipantsAlex Braun - Head IRDaniel O'Connell - President and Chief...
27 mars 2023
iO Charts is a Seeking Alpha partner
UTDELNING
ABOS Betalar inte utdelning
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
27 mars 2023
iO Charts is a Seeking Alpha partner
Acumen Pharmaceuticals is an early-stage developmental concern focusing on development treatments for Alzheimer's. Click here to read ABOS' investment analysis.
26 december 2022
iO Charts is a Seeking Alpha partner
UTVÄRDERING
Värderingsvillkor
Loading...
Data om värderingsgrad
| Efterföljande P/E | - |
| Pris till OCF | - |
| Pris till FCF | - |
| Pris till EBITDA | - |
| EV i förhållande till EBITDA | - |
Värdering (Försäljning/Bokfört värde)
Loading...
Värderingsdata (försäljning/bokfört värde)
| Pris till omsättning | - |
| Pris till eget kapital | 0.85 |
| EV i förhållande till försäljning | - |
Acumen Pharmaceuticals (ABOS) Q3 2022 Earnings Conference Call Nov 14, 2022 04:30 PM ET
15 november 2022
iO Charts is a Seeking Alpha partner
The following slide deck was published by Acumen Pharmaceuticals, Inc.
14 november 2022
iO Charts is a Seeking Alpha partner
EKONOMI
Per aktie
Loading...
Data per aktie
| Nuvarande aktiemängd | 40.93M |
| EPS (TTM) | -0.95 |
| FCF per aktie (TTM) | -0.69 |
Resultaträkning
Loading...
Uppgifter om resultaträkningen
| Intäkter (TTM) | 0.00 |
| Bruttovinst (TTM) | 0.00 |
| Rörelseintäkter (TTM) | -39.40M |
| Nettoresultat (TTM) | -38.34M |
| EPS (TTM) | -0.95 |
| EPS (1 år framåt) | -1.22 |
Marginaler
Loading...
Marginer-data
| Bruttomarginal (TTM) | - |
| Rörelsemarginal (TTM) | - |
| Vinstmarginal (TTM) | - |
Balans
Loading...
Skapa ett gratis konto eller logga in för att komma åt det här diagrammet
Uppgifter om balansräkningen
| Kontanter | 157.54M |
| Nettofordringar | 121.00K |
| Summa omsättningstillgångar | 202.56M |
| Goodwill | 0.00 |
| Immateriella tillgångar | 0.00 |
| Materiella anläggningstillgångar | 0.00 |
| Summa tillgångar | 203.26M |
| Leverantörsskulder | 2.08M |
| Kortfristig/kortfristig långfristig skuld | 133.00K |
| Summa kortfristiga skulder | 6.61M |
| Summa skulder | 6.61M |
| Eget kapital | 196.65M |
| Materiella anläggningstillgångar netto | 196.65M |
Kassaflöde
Loading...
Skapa ett gratis konto eller logga in för att komma åt det här diagrammet
Uppgifter om kassaflöde
| Kassaflöde från den löpande verksamheten (TTM) | -27.59M |
| Investeringar (TTM) | 158.00K |
| Fritt kassaflöde (TTM) | -27.75M |
| Utbetald utdelning (TTM) | 0.00 |
Finansiella intäkter
Loading...
Skapa ett gratis konto eller logga in för att komma åt det här diagrammet
Uppgifter om finansiella intäkter
| Avkastning på eget kapital | -19.50% |
| Avkastning på tillgångar | -18.86% |
| Avkastning på investerat kapital | -19.48% |
| Kontantavkastning på investerat kapital | -14.10% |
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
14 november 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
24 oktober 2022
iO Charts is a Seeking Alpha partner
INFORMATION OM AKTIER
Aktiediagram
Loading...
Uppgifter om aktiekurs
| Öppning | 3.96 |
| Dagens högsta | 4.19 |
| Daglig låg | 3.90 |
| Daglig volym | 53K |
| Den högsta någonsin | 20.28 |
| 1 års analytikeruppskattning | 15.83 |
| Beta | - |
| EPS (TTM) | -0.95 |
| Utdelning per aktie | - |
| Ex-div datum | - |
| Nästa datum för resultatpresentation | 27 Mar 2023 |
Potential på nackdelen
Loading...
Negativa potentiella data
| ABOS | S&P500 | |
| Nuvarande prisfall från toppnotering | -79.88% | -17.92% |
| Högsta prisfallet | -84.81% | -56.47% |
| Datum för högsta fall | 11 May 2022 | 9 Mar 2009 |
| Genomsnittligt fall från topp | -61.23% | -11.51% |
| Genomsnittlig tid till ny topp | 434 days | 13 days |
| Maxtid till ny topp | 433 days | 1805 days |
Acumen's share price more than doubled because of the Eisai news on lecanemab. Here's why I think ABOS' stock price is unsustainable.
30 september 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
28 september 2022
iO Charts is a Seeking Alpha partner
UPPLYSNINGAR OM FÖRETAG
Marknadsvärde
166.98M
Kategori av marknadsvärde
Small-cap
Beskrivning: __________
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Anställda
14
Webbplats
Investerarrelationer
-
SEC-inlämningar
Verkställande direktör
Land
USA
By
Typ av aktie
-
CCC-status
-
Utdelningsfrekvens
-
EVENEMANG OCH PRESENTATIONER
EvenemangPresentationer
Loading...
Acumen Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ABOS) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ETCompany ParticipantsJohn Woolford - Investor Relations, WestwickeDaniel...
16 augusti 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
15 augusti 2022
iO Charts is a Seeking Alpha partner
FÖRSTÅ VERKSAMHETEN
Loading...
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week
30 juli 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
30 juni 2022
iO Charts is a Seeking Alpha partner
NYHETER OM FÖRETAGET
Alla nyheterPressmeddelanden
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2022 Earnings Call Transcript March 27, 2023 Operator: Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2022 Conference Call and Web...
29 mars 2023
Data describe induced pluripotent stem cell (iPSC)-derived excitatory neurons as a human model for assessing selectivity of drug binding to soluble amyloid beta oligomers in Alzheimer’s diseaseResults...
28 mars 2023
INTERCEPT-AD, a Phase 1 clinical trial of ACU193 in patients with early Alzheimer’s disease, completed enrollment in February 2023 Topline data expected in the third quarter of 2023 Cash, cash equival...
27 mars 2023
CHARLOTTESVILLE, Va. and CARMEL, Ind., March 22, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that ta...
22 mars 2023
CHARLOTTESVILLE, Va. and CARMEL, Ind., March 20, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical developing a novel therapeutic that targets to...
20 mars 2023
CHARLOTTESVILLE, Va. and CARMEL, Ind., March 08, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that ta...
8 mars 2023
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
15 februari 2023
Topline results including safety and proof-of-mechanism data expected in third quarter of 2023CHARLOTTESVILLE, Va. and CARMEL, Ind., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NAS...
13 februari 2023
Here is how Novo Nordisk (NVO) and Acumen Pharmaceuticals, Inc. (ABOS) have performed compared to their sector so far this year.
6 januari 2023
CHARLOTTESVILLE, Va. and CARMEL, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
4 januari 2023
Nästa sida
Acumen Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ABOS) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ETCompany ParticipantsJohn Woolford - IR, WestwickeDaniel O'Connell - President &...
17 maj 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Acumen Pharmaceuticals, Inc. (ABOS) stock at Seeking Alpha.
16 maj 2022
iO Charts is a Seeking Alpha partner